Skip to main content

Table 1 Referral values for morbidity rate in the IMI-CNMR study and in the international

From: The surgical treatment of non-metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): a retrospective cohort quality improvement study to reduce the morbidity rates

Surgical Indicators Benchmark referral values
Procedure   Present study International
WE Wound infection 1.1% (0.4 to 2.7%) 4.6–8.4%a
Wound dehiscence 2.0% (0.8 to 5.1%) 3.5–4.6%a
Skin graft failure unreliable < 2%a
SLNB Wound Infection 1.3% (0.7 to 2.5%) 2.9% (1.5 to 4.6%)b
Wound dehiscence 0.9% (0.2 to 3.0%) 0.24–1.2%a
Seroma 4.2% (1.5 to 11.1%) 5.1% (2.5 to 8.6%)b
LFND Wound infection 4.1% (2.1 to 8.0%) 15.8%a
Wound dehiscence 2.8% (0.9 to 8.6%) 3%a
Wound infection and/or dehiscence 6.5% (2.9 to 14.0%) 21.6% (13.8 to 30.6%)c
Seroma 15.1% (4.6 to 39.9%) 17.9% (10.3 to 27%)c
  1. Data expressed as percentage with 95% confidence interval in parentheses
  2. aMorton DL, Cochran AJ, Thompson JF, Elashoff R, Essner R, Glass EC, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ, Wang HJ; Multicenter Selective Lymphadenectomy Trial Group. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg. 2005 Sep;242 (3):302–11; discussion 311–3
  3. bMoody JA, Ali RF, Carbone AC, Singh S, Hardwicke JT. Complications of sentinel lymph node biopsy for melanoma-A systematic review of the literature. Eur J Surg Oncol. 2017;43:270–277
  4. cMoody JA, Botham SJ, Dahill KE, Wallace DL, Hardwicke JT. Complications following completion lymphadenectomy versus therapeutic lymphadenectomy for melanoma - A systematic review of the literature. Eur J Surg Oncol. 2017;43:1760–1767